Clinical trial · Interventional
Prospective Random Comparing Study on EUS-guided Pseudocyst Drainage by Naso-pancreatic Tube and Stents
Random Comparing Study on Two Different EUS-guided Pseudocyst Drainage Methods--Modified Naso-pancreatic Tube Drainage and Stents Drainage
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
EUS-guided pseudocyst drainage has been used world widely. Now, most endoscopists tend to place several stents to drain the content of cyst into GI tract. In the investigators experience, a modified naso-pancreatic tube drainage was more safer, easier and cheaper than placement of stents. Moreover, none of pseudocysts(total 19) drained by this modified naso-pancreatic tube drainage method were found recurrent with a follow up period from 3 months-34 months. So, the investigators designed this prospective random comparing study to confirm the result.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Pancreatic Pseudocyst | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| EUS-guided pancreatic pseudocyst drainage | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Naso-pancreatic tube
- description
- The patients enrolled in this group will be treated with modified naso-pancreatic tube drainage method.
- interventionNames
- Procedure: EUS-guided pancreatic pseudocyst drainage
- type
- EXPERIMENTAL
- label
- Stents
- description
- The patients enrolled this group will be treated by placing the stents (at least 2 stents) between gastric and pancreatic pseudocyst.
- interventionNames
- Procedure: EUS-guided pancreatic pseudocyst drainage
Primary outcomes (1)
- measure
- recurrence rate of pancreatic pseudocyst
- timeFrame
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 85 Years
Show eligibility criteria text
Inclusion Criteria: 1. Adults with ages from 18-80 years old. 2. The pseudocysts were formed more than 3 months. 3. The size of pseudocyst is more than 5 cm. 4. The patient has the symptoms related with the pseudocyst. 5. The distance between gastric and the wall of the pseudocyst is less than 1 cm from CT image. 6. The consent form has been signed. Exclusion Criteria: 1. The patient can't accept the endoscopic procedure. 2. The patient has blood coagulation dysfunction. 3. The patient has mental disorders. 4. The patient has mild or severe cardiorespiratory insufficiency. 5. The patient has hypertension and can't be controlled to safe level. 6. Diabetics whose blood sugar level can't be controlled to safe level. 7. Patients with alcohol dependence 8. Pregnant and lactating women. 9. The patients the investigator don't think suitable for this study.
References
Publications (4)
- BACKGROUNDBaron TH, Wiersema MJ. EUS-guided transesophageal pancreatic pseudocyst drainage. Gastrointest Endosc. 2000 Oct;52(4):545-9. doi: 10.1067/mge.2000.108928. No abstract available. PMID 11023579
- BACKGROUNDSeewald S, Thonke F, Ang TL, Omar S, Seitz U, Groth S, Zhong Y, Yekebas E, Izbicki J, Soehendra N. One-step, simultaneous double-wire technique facilitates pancreatic pseudocyst and abscess drainage (with videos). Gastrointest Endosc. 2006 Nov;64(5):805-8. doi: 10.1016/j.gie.2006.07.049. PMID 17055880
- BACKGROUNDLopes CV, Pesenti C, Bories E, Caillol F, Giovannini M. Endoscopic-ultrasound-guided endoscopic transmural drainage of pancreatic pseudocysts and abscesses. Scand J Gastroenterol. 2007 Apr;42(4):524-9. doi: 10.1080/00365520601065093. PMID 17454865
- BACKGROUNDBarthet M, Lamblin G, Gasmi M, Vitton V, Desjeux A, Grimaud JC. Clinical usefulness of a treatment algorithm for pancreatic pseudocysts. Gastrointest Endosc. 2008 Feb;67(2):245-52. doi: 10.1016/j.gie.2007.06.014. PMID 18226686